1. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015) Authors: Chau, I.; Park, J.O.; Ryoo, B.Y.; Yen, C.J.; Poon, R.; Pastorelli, D.; Blanc, J.F.; Kudo, M.; Pfiffer, T.F.; Hatano, E.; Chung, H.C.; Kubackova, K.; Phelip, J.M.; Brandi, G.; Ohkawa, S.; Li, C.P.; Okusaka, T.; Yang, L.; Abada, P.; Zhu, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer. Issue 9 (September 2016) Authors: Rho, Y.S.; Gilabert, M.; Polom, K.; Aladashvili, A.; Kubackova, K.; Megdanova, V.; Coleman, N.; Greally, M.; Marrelli, D.; Roviello, F.; McDermott, R.; Petrova, V.; Mihaylova, Z.; Zbynek, B.; Peausova, J.; Batist, G.; Azoulay, L.; Kavan, P. Journal: European journal of surgical oncology Issue: Volume 42:Issue 9(2016:Sep.) Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INCIDENCE AND OUTCOME OF PRIMARY EXTRANODAL FOLLICULAR LYMPHOMAS. ANALYSIS FROM THE CZECH LYMPHOMA STUDY GROUP (CLSG) REGISTRY. (June 2017) Authors: Janikova, A.; Campr, V.; Kopalova, N.; Benesova, K.; Belada, D.; Dlouha, J.; Duras, J.; Prochazka, V.; Mocikova, H.; Kubackova, K.; Sykorova, A.; Brejcha, M.; Mayer, J.; Trneny, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗